A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Combination Therapy of T-614 and Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate

NCT00965757 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
253
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Eisai Co., Ltd.

Collaborators